CSIMarket
 
T2 Biosystems Inc   (TTOO)
Other Ticker:  
 

T2 Biosystems Inc

Business Description


T2 Biosystems Inc is a medical technology company that specializes in the development and commercialization of innovative diagnostic products. The company is headquartered in Lexington, Massachusetts, and was founded in 2006 by a team of scientists, engineers, and business professionals.

T2 Biosystems focuses on revolutionizing diagnostics by combining the power of magnetic resonance (MR) technology and miniaturized nanoparticles to create rapid and accurate tests for various infectious diseases, including sepsis, Lyme disease, and various other hemostasis disorders.

The flagship product of T2 Biosystems is the T2Dx Instrument, a fully automated platform that utilizes the T2 Magnetic Resonance (T2MR) technology. This technology enables the detection of pathogens, toxins, and biomarkers directly from whole blood in a matter of hours, providing faster and more precise results compared to traditional culture-based methods.

The T2Dx Instrument, along with the company*s proprietary T2Candida and T2Bacteria panels, is designed to aid healthcare professionals in making informed treatment decisions rapidly. The T2Candida panel is the first FDA-cleared test for the detection of Candida infections, which are the leading cause of sepsis in ICU patients. The T2Bacteria panel, on the other hand, is the first direct-from-blood diagnostic test for bloodstream infections caused by pathogens like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

The innovative nature of T2 Biosystems* technology lies in its ability to detect pathogens directly from clinical blood samples without the need for time-consuming blood culture procedures. This eliminates the delay associated with traditional culture-based methods, where it often takes several days to get results, enabling clinicians to administer timely and appropriate patient treatment.

T2 Biosystems has also expanded its product portfolio beyond infectious diseases. They have developed tests like the T2Hemostasis panel, which aids in the identification of hemostasis disorders like sepsis-induced coagulopathy and disseminated intravascular coagulation. Additionally, the company is actively engaged in research and development efforts to explore new applications for its T2MR technology in fields such as oncology and drug monitoring.

T2 Biosystems has received numerous accolades for its groundbreaking technologies, including FDA clearances and approvals, as well as recognition from prestigious medical and scientific organizations. The company has formed collaborations and partnerships with leading healthcare institutions and organizations worldwide to ensure widespread adoption of its innovative diagnostic solutions.

In summary, T2 Biosystems Inc is a pioneering medical technology company that leverages magnetic resonance technology and miniaturized nanoparticles to develop highly accurate and rapid diagnostic tests for infectious diseases and other medical conditions. Their innovative approach has the potential to revolutionize diagnostics and improve patient outcomes by enabling timely and targeted treatments.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com